Insider filing · BBIO
Thomas Trimarchi
President and CFO
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
Thomas Trimarchi sold $1.1M of BridgeBio Pharma (BBIO)
Executed Nov 17 2025, disclosed Nov 18 2025, 1 day later.
Value, as filed
$1.1M
16,934 sh across 2 lots
Executed
Nov 17 2025
the trade date, as filed
Disclosed
Nov 18 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TTThomas Trimarchi (President and CFO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $1.1M of BBIO (16,934 sh across 2 lots, as filed), executed Nov 17 2025.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Thomas Trimarchi in BBIO
BBIOSALE
BridgeBio Pharma, Inc.
$888K13,651 sh across 2 lots
Exec May 18
Filed May 19 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. $1.0M
13,400 sh × $74.71
Exec Feb 17
Filed Feb 18 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. $2.1M
42,237 sh × $49.48
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. $872K
17,353 sh across 2 lots
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET